Asian Biomedicine

Scope & Guideline

Empowering Innovation in Biomedicine

Introduction

Welcome to your portal for understanding Asian Biomedicine, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1905-7415
PublisherWALTER DE GRUYTER GMBH
Support Open AccessNo
CountryThailand
TypeJournal
Convergefrom 2008 to 2024
AbbreviationASIAN BIOMED / Asian Biomed.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGENTHINER STRASSE 13, D-10785 BERLIN, GERMANY

Aims and Scopes

The journal 'Asian Biomedicine' is dedicated to advancing the understanding of biomedical sciences with a focus on the diverse health-related challenges faced in the Asian context. It emphasizes the integration of basic science and clinical research, aiming to foster innovative approaches to health care and disease management.
  1. Clinical and Translational Research:
    The journal emphasizes clinical studies that bridge the gap between laboratory findings and patient care, highlighting research that can lead to improved health outcomes.
  2. Genetic and Molecular Studies:
    A core area of focus is the exploration of genetic factors and molecular mechanisms underlying diseases, including cancer, cardiovascular conditions, and genetic disorders.
  3. Infectious Diseases and Public Health:
    The journal publishes research on infectious diseases prevalent in Asia, including epidemiological studies, treatment strategies, and public health interventions.
  4. Innovative Diagnostic and Therapeutic Approaches:
    There is a significant interest in novel diagnostic tools and therapeutic methods, particularly those that leverage advancements in technology and personalized medicine.
  5. Maternal and Child Health:
    Research addressing maternal and child health issues is a prominent area, reflecting the journal's commitment to improving health outcomes in vulnerable populations.
  6. Chronic Disease Management and Prevention:
    The journal focuses on research related to chronic diseases, including diabetes, hypertension, and cancer, with an emphasis on prevention and management strategies.
Recent publications in 'Asian Biomedicine' have highlighted several trending and emerging themes that reflect the evolving landscape of biomedical research and the pressing health issues faced in Asia.
  1. Predictive Analytics in Health Care:
    There is a growing trend towards the use of predictive models and analytics to understand disease severity and outcomes, particularly in cardiovascular and oncological research.
  2. Genomic Medicine and Personalized Therapy:
    Emerging themes include the application of genomic sequencing and personalized medicine approaches in the treatment of various cancers and genetic disorders.
  3. COVID-19 Related Research:
    The journal has seen an increased focus on COVID-19, encompassing studies on immunity, vaccination, and the long-term effects of the virus on health.
  4. Nutritional and Lifestyle Interventions:
    Research on the impact of diet and lifestyle on chronic diseases, particularly in populations with specific dietary habits, is gaining attention.
  5. Immunology and Autoimmune Disorders:
    There is an emerging focus on immunological research, particularly in relation to autoimmune diseases and their management.
  6. Telemedicine and Digital Health Solutions:
    The rise of telemedicine and digital health technologies is increasingly featured, reflecting a shift towards innovative care delivery models.

Declining or Waning

While 'Asian Biomedicine' covers a broad range of biomedical topics, certain themes have shown a decline in focus over the recent years. These waning scopes may reflect shifting priorities in research funding, public health concerns, or emerging health challenges.
  1. Traditional Medicine:
    There has been a noticeable reduction in the publication of studies related to traditional or alternative medicine practices, which may be attributed to a growing emphasis on evidence-based approaches.
  2. Environmental Health Studies:
    Research focusing on the direct impact of environmental factors on health has declined, possibly overshadowed by more pressing clinical and epidemiological studies.
  3. Psychosocial Interventions in Health:
    There is a waning interest in studies that explore psychosocial factors and interventions in health, as the focus shifts towards more quantifiable biomedical approaches.
  4. Animal Models in Biomedical Research:
    The use of animal models in certain areas of research, particularly in the context of chronic diseases, appears to be decreasing, likely due to ethical considerations and a push for alternative methods.

Similar Journals

Advanced Biomedical Research

Fostering Open Access to Pioneering Biomedical Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2277-9175Frequency:

Advanced Biomedical Research, published by Wolters Kluwer Medknow Publications, is a prominent open access journal dedicated to advancing the field of biomedical research since its inception in 2012. With an ISSN of 2277-9175, this journal serves as a vital platform for researchers, professionals, and students to disseminate high-quality research findings and innovative ideas in a variety of topics within biochemistry, genetics, and molecular biology. Recognized within the Q3 category of the 2023 journal quartile rankings, it ranks 365th among general medicine journals and 187th in the general fields of biochemistry and genetics, underscoring its commitment to fostering scientific dialogue and collaboration. With its open access model, Advanced Biomedical Research ensures that research is readily accessible to a global audience, thereby enhancing the visibility and impact of scholarly work. As the journal continues to evolve through its converged editorial focus from 2019 to 2024, it aims to play a critical role in shaping the future of biomedical sciences in India and beyond.

M S-MEDECINE SCIENCES

Bridging theory and practice in life sciences.
Publisher: EDP SCIENCES S AISSN: 0767-0974Frequency: 12 issues/year

M S-MEDECINE SCIENCES, published by EDP SCIENCES S A, is an esteemed journal based in France dedicated to the fields of biochemistry, genetics, and medicine. With an ISSN of 0767-0974 and an E-ISSN of 1958-5381, this journal has been a platform for scholarly communication since its inception in 1990 and continues to present critical advancements in these scientific domains, aiming to bridge theoretical research with practical applications. Despite its current Q4 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, the journal aspires to enhance its visibility and impact within the academic community. Researchers and professionals can benefit from a wealth of studies that contribute to the understanding of complex biological systems and medical innovations. Interested authors are encouraged to explore the journal's submission guidelines and contribute to the growing body of knowledge in these important fields.

ARCHIVES OF MEDICAL RESEARCH

Advancing medical knowledge through rigorous research.
Publisher: ELSEVIER SCIENCE INCISSN: 0188-4409Frequency: 8 issues/year

Archives of Medical Research is a prestigious scholarly journal dedicated to advancing the field of medicine through the dissemination of high-quality research findings. Published by Elsevier Science Inc., this esteemed journal has garnered significant recognition, boasting a remarkable impact factor and ranking in the top quartile (Q1) of its category, specifically in General Medicine with a Scopus rank of #30 out of 636 journals, placing it in the 95th percentile. Since its inception in 1992, Archives of Medical Research has served as a critical platform for researchers and professionals to share innovative insights and empirical studies that address pressing medical issues and enhance clinical practices. The journal welcomes a range of submissions, ensuring a diverse array of topics that reflect the latest trends and developments in medicine. As the journal continues to push the boundaries of medical research until at least 2025, it remains an essential resource for students, academics, and healthcare professionals striving to make a meaningful impact in the medical community.

EXCLI Journal

Connecting Scientists for a Healthier Tomorrow
Publisher: EXCLI JOURNAL MANAGING OFFICEISSN: 1611-2156Frequency:

EXCLI Journal is an esteemed open access scientific publication dedicated to the fields of Animal Science and Zoology, Drug Discovery, Molecular Medicine, and Pharmacology. Established in 2002 and published by the EXCLI JOURNAL MANAGING OFFICE, this journal has quickly ascended in the academic community, securing a Q1 classification in significant categories like Animal Science and Drug Discovery in the 2023 rankings. With an impressive Scopus Rank of #13 out of 490 in its primary field, the journal maintains high standards for quality research and innovation. The EXCLI Journal is committed to disseminating progressive findings with global relevance, providing a platform for researchers, professionals, and students to engage with cutting-edge studies. With a compelling aim to foster knowledge exchange and collaboration among scientists worldwide, this journal signifies a critical resource for those invested in advancing our understanding of animal science and pharmaceutical research.

International Journal of Clinical and Experimental Medicine

Unlocking Insights in Biochemistry and Genetics
Publisher: E-CENTURY PUBLISHING CORPISSN: 1940-5901Frequency: 12 issues/year

International Journal of Clinical and Experimental Medicine, an esteemed publication by E-CENTURY PUBLISHING CORP, serves as a vital resource for researchers and professionals in the fields of biochemistry, genetics, and molecular biology. Since its inception in 2009 and continuing until 2017, the journal has presented a wealth of knowledge aimed at fostering innovation and collaboration within the scientific community. Although the coverage has been discontinued in Scopus, the journal has established itself within the academic discourse, evidenced by its ranking in the 28th percentile for General Biochemistry, Genetics and Molecular Biology. As an open-access publication, it ensures widespread dissemination of research findings, making it a crucial platform for the advancement of clinical and experimental medicine. With its commitment to high-quality peer-reviewed articles, the International Journal of Clinical and Experimental Medicine remains a significant contribution to the body of knowledge in its field, serving as an invaluable tool for students, researchers, and practitioners alike.

Nigerian Journal of Basic and Clinical Sciences

Fostering scholarly communication in basic and clinical sciences.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0331-8540Frequency: 2 issues/year

Nigerian Journal of Basic and Clinical Sciences, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating research in the fields of health policy, medicine, and public health, specifically addressing the unique challenges and advancements within these areas in Nigeria and beyond. With an impressive array of contributions, this journal, recognized under the ISSN 0331-8540 and E-ISSN 2320-477X, aims to foster scholarly communication and offer innovative insights particularly pertinent to developing regions. Despite being positioned in the Q4 category for various medical fields in 2023 and receiving low Scopus ranks, the journal stands out as a valuable resource for aspiring researchers, healthcare professionals, and students aiming to explore basic and clinical sciences. While it follows a traditional publication model, it remains an indispensable source for cutting-edge research and case studies that can significantly impact health outcomes. The journal has been consistently publishing since its inception in 2012 and continues to play an important role in advancing the academic discourse within its scope.

FASEB JOURNAL

Advancing the Frontiers of Biological Science
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

Immuno

Driving Progress in Immunological Science and Applications
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

Byulleten Sibirskoy Meditsiny

Connecting Innovators in Biomedical Sciences
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Pulmonology

Advancing lung health through groundbreaking research.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.